Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology
Summary
Our report, “Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology”” provides key information and analysis on the Boston Scientific’s investment in Cameron Health. The report provides comprehensive information on deal rationale and global Implantable Cardioverter Defibrillator (ICD) market.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- The report provides qualitative information on rationale behind Boston Scientific’s investment in Cameron Health. - Annualized market revenue data for global ICD market for 2009 and forecast forward to 2016. - Qualitative analysis on investment in Cameron Health by Boston Scientific.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the global ICD market. - Understand the key technologies that are expected to drive the ICD market in the future. - Exploit M&A opportunities by identifying key areas of growth. - Make more informed business decisions from the insightful and in-depth analysis of the global ICD market and the factors shaping it.
